Physician profile
Robert D Brown
NPI 1396784443
$2,432.64
in general payments reported to CMS, 2019-2025
18 companies · $87.93 in 2025
The $87.93 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $345 · 2021: $354 · 2022: $501 · 2023: $309 · 2024: $219 · 2025: $87.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.16 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,005.31 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $365.04 | 2019-2025 | |
| Lilly USA, LLC | $303.01 | 2019-2022 | |
| Janssen Biotech, INC. | $202.15 | 2019-2023 | Tremfya |
| Sun Pharmaceutical Industries INC. | $134.86 | 2020-2022 | |
| Genzyme Corporation | $71.87 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $61.86 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $51.57 | 2024 | Sotyktu |
| Genentech USA, INC. | $44.65 | 2019-2020 | |
| Kyowa Kirin, INC. | $40.88 | 2021-2023 | Poteligeo |
| Mayne Pharma Commercial LLC | $24.91 | 2024 | |
| Janssen Scientific Affairs, LLC | $22.55 | 2020 | |
| Incyte Corporation | $22.38 | 2022 | |
| Amgen INC. | $21.52 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.53 | 2023 | Spevigo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $15.91 | 2020 | |
| Ucb, INC. | $12.92 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $12.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.